논문KCI 등재
Towards Steroid-Free Immunosuppression after Liver Transplantation
1
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (10)
- Padbury RT, "Steroid withdrawal from long-term immunosuppression in liver allograft recipients", Transplantation, 55, pp.789~794 (1993)
- Punch JD, "Corticosteroid withdrawal after liver transplantation", Surgery, 118, pp.783~786 (1995)
- De Carlis L, "Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial", Transplant Proc, 29, pp.539~542 (1997)
- Pelletier SJ, "A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years", HPB, 15, pp.286~293 (2013)
- steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebocontrolled, randomized, investigator-driven study, "Ann Surg", 2014, 886~891
- Miyagi S, "The relationship between recurrences and immunosuppression on living donor liver transplantation for hepatocellular carcinoma", Transplant Proc, 44, pp.797~801 (2012)
- Xing T, "Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma", PLoS One, 8, pp.e71251~ (2013)
- Qiang Wei, "Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma", Gut and Liver, 10(4), pp.604~610 (2016), 거트앤리버 발행위원회
- Zaydfudim V, "Reduction in corticosteroids is associated with better health-related quality of life after liver transplantation", J Am Coll Surg, 214, pp.164~173 (2012)
- Annema C, "Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation", Liver Transpl, 21, pp.524~538 (2015)
관련 논문AI추천
Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular CarcinomaChao Wang, Haiyang Xie, Jian Wu, Lin Zhou, Li Zhuang, Min Zhang, Qiang Wei, Runzhou Zhuang, Shusen Zheng, Weilin Wang, Xiao Xu, Yan Shen거트앤리버 소화기연관학회협의회 · Gut and Liver2016 · 제10권 제4호How to optimize the outcome of liver transplantation for non-alcoholic fatty liver diseaseByeong Geun Song, Dong Hyun Sinn대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Independent Predictors for Primary Non-Function after Liver Transplantation오창권, Hilary A. Sanfey, Robert G. Sawyer, Shawn J. Pelletier, Timothy L. Pruett연세대학교의과대학 · Yonsei Medical Journal2004 · 제45권 제6호The impact of ischemia-free liver transplantation on improving the prognosis of recipients using functionally marginal liver grafts: Editorial on “Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver grafts”Ho Joong Choi대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Revolution and Refinement of Surgical Techniques for Living Donor Partial Liver TransplantationEnder Dulundu, Masatoshi Makuuchi, Yasuhiko Sugawara연세대학교의과대학 · Yonsei Medical Journal2004 · 제45권 제6호Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation홍근, 김주현, 김혜영, 문미라, 박민수, 서경석, 서석원, 유태석, 이광웅, 이남준, 이정무, 이주연, 이해원, 정재홍, 최영록대한간학회 · Clinical and Molecular Hepatology2014 · 제20권 제3호
이 간행물의 다른 논문 (28건)
The Efficiency of Intravenous Iron Therapy in Korean Inflammatory Bowel Disease PatientsKyeong Ok Kimpp. 487-488Is Elderly Age a Simple Predictive Factor for Inadequate Bowel Preparation before Colonoscopy?Hyun Gun Kimpp. 489-490Serum Procalcitonin Is a Candidate Biomarker to Differentiate Bacteremia from Disease Flares in Patients with Inflammatory Bowel DisSeong-Eun Kimpp. 491-492Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection김유선, Jung Hwa Minpp. 493-494Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?Jeong-Hoon Lee, Jung-Hwan Yoon, Eun Ju Chopp. 497-498
